Phase 2 randomised study of bulevirtide as monotherapy or combined with Peg-IFNα-2a as treatment for chronic hepatitis delta - Lampertico, Pietro; Bogomolov, Pavel O.; Chulanov, Vladimir; Stepanova, Tatiana; Morozov, Viacheslav; Allweiss, Lena; Dandri, Maura; Burhenne, Jürgen; Blank, Antje; Ciesek, Sandra; Elsner, Carina; Dittmer, Ulf; et al. (Liver international, 2025)
Gesehen am 30.09.2025